ENVUE MEDICAL INC NEW
FEED
FEED was delisted on the 15th of September, 2026.
4 hedge funds and large institutions have $142K invested in ENVUE MEDICAL INC NEW in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
1.11% less ownership
Funds ownership: 3.6% → 2.49% (-1.1%)
20% less funds holding
Funds holding: 5 → 4 (-1)
30% less capital invested
Capital invested by funds: $204K → $142K (-$61.5K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$51.3K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$12.6K |
FEED Hedge Fund Activity: Q2 2023 in Review
4 of the 6,384 institutional investors tracked by Wall St. Rank reported a position in ENVUE MEDICAL INC NEW (FEED) for Q2 2023, worth a combined $142K — down 30% from $204K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of FEED and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest seller was Vanguard Group, cutting an estimated $51.3K.
- 4 institutional investors held ENVUE MEDICAL INC NEW (FEED) as of Q2 2023, down from 5 in Q1 2023.
- Funds reported $142K of ENVUE MEDICAL INC NEW stock for Q2 2023, down 30% quarter-over-quarter.
- 0 funds opened new ENVUE MEDICAL INC NEW positions in Q2 2023 and 1 closed out, a net change of -1 holder.
- The largest ENVUE MEDICAL INC NEW seller in Q2 2023 was Vanguard Group, an estimated $51.3K sold.
Based on aggregated 13F filings for Q2 2023.